
Brad Harcourt
Examiner (ID: 13463, Phone: (571)272-7303 , Office: P/3676 )
| Most Active Art Unit | 3674 |
| Art Unit(s) | 3676, 3674, 3672 |
| Total Applications | 1627 |
| Issued Applications | 1317 |
| Pending Applications | 101 |
| Abandoned Applications | 231 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3792565
[patent_doc_number] => 05726148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Method of treating metabolic bone diseases with an IL-1 receptor'
[patent_app_type] => 1
[patent_app_number] => 8/487646
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1749
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726148.pdf
[firstpage_image] =>[orig_patent_app_number] => 487646
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487646 | Method of treating metabolic bone diseases with an IL-1 receptor | Jun 6, 1995 | Issued |
Array
(
[id] => 4098833
[patent_doc_number] => 06048837
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'OB polypeptides as modulators of body weight'
[patent_app_type] => 1
[patent_app_number] => 8/485942
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 35
[patent_no_of_words] => 62303
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048837.pdf
[firstpage_image] =>[orig_patent_app_number] => 485942
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485942 | OB polypeptides as modulators of body weight | Jun 6, 1995 | Issued |
| 08/474833 | OB PROTEIN COMPOSITIONS AND METHODS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4051631
[patent_doc_number] => 05932537
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Method for attenuating a cellular response to IL-1'
[patent_app_type] => 1
[patent_app_number] => 8/479140
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 16431
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932537.pdf
[firstpage_image] =>[orig_patent_app_number] => 479140
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479140 | Method for attenuating a cellular response to IL-1 | Jun 6, 1995 | Issued |
Array
(
[id] => 4156199
[patent_doc_number] => 06124439
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-26
[patent_title] => 'OB polypeptide antibodies and method of making'
[patent_app_type] => 1
[patent_app_number] => 8/488214
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 68
[patent_no_of_words] => 60104
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/124/06124439.pdf
[firstpage_image] =>[orig_patent_app_number] => 488214
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488214 | OB polypeptide antibodies and method of making | Jun 6, 1995 | Issued |
Array
(
[id] => 3821365
[patent_doc_number] => 05783181
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins'
[patent_app_type] => 1
[patent_app_number] => 8/470299
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10315
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783181.pdf
[firstpage_image] =>[orig_patent_app_number] => 470299
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470299 | Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins | Jun 5, 1995 | Issued |
Array
(
[id] => 4045725
[patent_doc_number] => 05874561
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'DNA, host cell and vector encoding a protein with cytokine inhibitory activity'
[patent_app_type] => 1
[patent_app_number] => 8/471227
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13753
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874561.pdf
[firstpage_image] =>[orig_patent_app_number] => 471227
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471227 | DNA, host cell and vector encoding a protein with cytokine inhibitory activity | Jun 5, 1995 | Issued |
Array
(
[id] => 3985135
[patent_doc_number] => 05861485
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Polypeptides involved in body weight disorders, including obesity'
[patent_app_type] => 1
[patent_app_number] => 8/470868
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 25
[patent_no_of_words] => 35259
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861485.pdf
[firstpage_image] =>[orig_patent_app_number] => 470868
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470868 | Polypeptides involved in body weight disorders, including obesity | Jun 5, 1995 | Issued |
Array
(
[id] => 3850366
[patent_doc_number] => 05767065
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4'
[patent_app_type] => 1
[patent_app_number] => 8/466324
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 37
[patent_no_of_words] => 24999
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767065.pdf
[firstpage_image] =>[orig_patent_app_number] => 466324
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466324 | Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4 | Jun 5, 1995 | Issued |
Array
(
[id] => 3933338
[patent_doc_number] => 05871723
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'CXC chemokines as regulators of angiogenesis'
[patent_app_type] => 1
[patent_app_number] => 8/468819
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 17
[patent_no_of_words] => 53553
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871723.pdf
[firstpage_image] =>[orig_patent_app_number] => 468819
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468819 | CXC chemokines as regulators of angiogenesis | Jun 5, 1995 | Issued |
Array
(
[id] => 4083398
[patent_doc_number] => 06025154
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Polynucleotides encoding human G-protein chemokine receptor HDGNR10'
[patent_app_type] => 1
[patent_app_number] => 8/466343
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 14871
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025154.pdf
[firstpage_image] =>[orig_patent_app_number] => 466343
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466343 | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 | Jun 5, 1995 | Issued |
Array
(
[id] => 3722921
[patent_doc_number] => 05702698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Methods of use of IL-1.alpha.'
[patent_app_type] => 1
[patent_app_number] => 8/461733
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 10819
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702698.pdf
[firstpage_image] =>[orig_patent_app_number] => 461733
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461733 | Methods of use of IL-1.alpha. | Jun 4, 1995 | Issued |
| 08/461246 | TUMOR NECROSIS FACTOR-GAMMA | Jun 4, 1995 | Abandoned |
| 08/462967 | HUMAN CHEMOKINE POLYPEPTIDES | Jun 4, 1995 | Abandoned |
Array
(
[id] => 3784146
[patent_doc_number] => 05840496
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Method for diagnosing endometrial cancer'
[patent_app_type] => 1
[patent_app_number] => 8/459814
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10239
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840496.pdf
[firstpage_image] =>[orig_patent_app_number] => 459814
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459814 | Method for diagnosing endometrial cancer | Jun 1, 1995 | Issued |
Array
(
[id] => 3876397
[patent_doc_number] => 05747444
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Method of treating graft-versus-host disease'
[patent_app_type] => 1
[patent_app_number] => 8/459811
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10232
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747444.pdf
[firstpage_image] =>[orig_patent_app_number] => 459811
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459811 | Method of treating graft-versus-host disease | Jun 1, 1995 | Issued |
Array
(
[id] => 3859625
[patent_doc_number] => 05795734
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'EPH receptor ligands, and uses related thereto'
[patent_app_type] => 1
[patent_app_number] => 8/455001
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 41853
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795734.pdf
[firstpage_image] =>[orig_patent_app_number] => 455001
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455001 | EPH receptor ligands, and uses related thereto | May 30, 1995 | Issued |
Array
(
[id] => 3881607
[patent_doc_number] => 05723119
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Method for enhancing wound healing/repair with IL-4'
[patent_app_type] => 1
[patent_app_number] => 8/451112
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10626
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723119.pdf
[firstpage_image] =>[orig_patent_app_number] => 451112
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451112 | Method for enhancing wound healing/repair with IL-4 | May 24, 1995 | Issued |
| 08/449182 | STEM CELL FACTOR | May 23, 1995 | Abandoned |
Array
(
[id] => 4011020
[patent_doc_number] => 05889156
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'TNF deletion muteins'
[patent_app_type] => 1
[patent_app_number] => 8/449689
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 17696
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/889/05889156.pdf
[firstpage_image] =>[orig_patent_app_number] => 449689
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449689 | TNF deletion muteins | May 23, 1995 | Issued |